Time for government to stop stalling National Pharmaceutical Strategy
Canada's public spending on drugs ranks 21st of 24 OECD industrialized countries. We have no coordinated national drug strategy to deal with this essential element of health care and drug coverage remains outside of our universal public insurance system.
Dealing with the H1N1 pandemic has provided some revealing glimpses into the mechanics of our health system and into the government currently in charge of its operation. What we've witnessed hasn't all been as pretty as the health minister would have us believe.
SPONSORED CONTENT
Get Tuesdays: Innovation & Industry Newsletter
The policies, decisions, and people working on investment and regulation in the industry and innovation realm.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
